✦ LIBER ✦

Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer

✍ Scribed by Jo, J-C; Lee, J-L; Ryu, M-H; Chang, H M; Kim, M; Lee, H J; Kim, H-S; Shin, J-G; Kim, T-W; Kang, Y-K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of irinotecan (CPT-11) as

✍ Donald Poon; Balram Chowbay; Yin-Bun Cheung; Swan-Swan Leong; Eng-Huat Tan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

3548 POSTER A phase II study of S-1 and

✍ B.Y. Ryoo; H.J. Kang; S.H. Yang; S.H. Cho; S.J. Oh; M.H. Lee; E.K. Song; H.C. Ch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase I dose escalation study of docetax

✍ Yeul Hong Kim; Hee Yeon Seo; Yoon Tae Jeen; Hoon-Kyo Kim; Byoung Yong Shim; Jinm 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 296 KB

Phase II study of S-1 and irinotecan com

✍ Hye J KANG; Sang H CHO; Suk J OH; Sung H YANG; Moon H LEE; Eun-Kee SONG; Hyun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

A phase II study of combination therapy

✍ Manabu Shiozawa; Makoto Akaike; Nobuhiro Sugano; Kazuhito Tsuchida; Naoto Yamamo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 347 KB

Phase I/II Pharmacokinetic and Pharmacog

✍ Yamamoto, N; Takahashi, T; Kunikane, H; Masuda, N; Eguchi, K; Shibuya, M; Takeda 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB